Home Search

COVID - search results

If you're not happy with the results, please do another search
image of lungs with SARS-CoV-2 particles on them to indicate infection and lung damage from COVID-19

A Molecular Decoy Provides 100% Protection against COVID-19 in Lab Studies

A molecular "decoy," a version of ACE2, protected 100 percent of study mice from COVID-19 when they were infected with an otherwise lethal dose of SARS-CoV-2.
image of lungs with SARS-CoV-2 particles on them to indicate infection and lung damage from COVID-19

Biomarkers Found for Rare Inflammatory Syndrome Linked to COVID-19 in Children

Using next generation sequencing, biomarkers of COVID-linked multisystem inflammatory syndrome (MIS-C) have been found. The biomarkers are linked to organ damage.
coronavirus cell or covid-19 cell

Gut Bacteria Impact COVID-19 Vaccine Response

Japanese research suggests that the digestion of fucose sugar by gut bacteria could impact the immune response to COVID-19 mRNA vaccines.
Photo of two hands held palm up with the left one holding a positive COVID-19 antigen test and the other holding a blood glucose monitor with a test strip inserted showing a reading of 126 to indicate the diabetes risks linked to SARS-CoV-2 infection.

COVID-19 Increases Risk of Developing Diabetes

Infection with SARS-CoV-19 increases the risk of developing incident diabetes after recovering from the infection. Naveed Janjua from the British Columbia Centre for Disease Control, and colleagues report that 3–5% of incident diabetes cases in the study could be attributed to COVID-19.
Woman using a nasal spray

Finnish Researchers Develop Nasal Spray That Protects against COVID

A team of researchers at the University of Helsinki, Finland, report they have developed a molecule that can be administered nasally to prevent the development of COVID-19 symptoms by all known variants of the SARS-CoV-2 virus.
Illustration of a blood clot in a vein to represent the risks of venous thromboembolism blood clots

Risk of Venous Thromboembolism after COVID-19 Low in Non-Hospitalized Patients

Overall risks of venous thromboembolism after COVID-19 are low in patients with less severe infections who do not require hospitalization.
Coronavirus particles, illustration - SARS-CoV-2 virus

New Drug Class Against COVID-19 Identified

Researchers have identified a potential new class of oral, antiviral drugs that could combat emerging coronaviruses and drug-resistant variants.
coronavirus cell or covid-19 cell

Researchers Develop First Nasal Monoclonal Antibody against COVID-19

Scientists use the nasal monoclonal antibody “Foralumab” to successfully decrease inflammation in patients with COVID-19.
Green and blue coronavirus cells under magnification intertwined with DNA cell structure

Breath Test Detects Even COVID Variants

A test using a puff of breath might be used to discern even variants of COVID-19 from non-COVID respiratory diseases.
Woman lying down suffering from symptoms of long covid after COVID-19

Presence of Specific Antibodies Could Be Protective against Long COVID

The presence of autoantibodies against inflammatory chemokines after COVID-19 could protect against the development of long COVID.


Inside Precision Medicine